Randox has launched two new liquid assayed chemistry controls, which it believes will revolutionize Quality Control in medical laboratories, saving time and money whilst ensuring highly accurate results and patient diagnosis.

The new controls, Acusera Liquid Assayed Chemistry Premium and Premium Plus, are designed to drastically cut the number of individual quality controls (QC) a laboratory needs to run in routine medical testing. Using the Randox controls laboratories can run QC on up to 100 analytes all within one test, without compromising performance or accuracy.

The concept of offering multi-analyte controls is not new. However, these latest assayed controls from Randox are the most comprehensive on the world market to date, containing a unique combination of proteins, lipids, immunoassays, cardiac markers, blood markers, therapeutic drugs and routine chemistry analytes.

The Acusera Chemistry Premium Plus control contains 100 analytes, whilst the Acusera Chemistry Premium control offers 91, with the following features:

• The high levels of CRP and other key proteins included eliminate the need for multiple controls, dramatically streamlining QC in laboratories.

• They are assayed controls, providing clinically significant values for a wide range of analysers at key decision points.

• Available in 3 concentration levels (low, mid and high), Premium Plus covers the full clinical range, removing the need for laboratories to purchase additional, and often expensive, low or high level controls.

• The controls are highly stable when stored at -20 to -70°C with open vial stability of up to 7 days at +2-8°c, reducing wastage in laboratories.

• As true third party controls, laboratories are assured of truly unbiased, independent assessment of analytical performance and as such help deliver highly accurate results and patient diagnosis.

The controls are now available in the UK, Europe, Middle East, Far East and Africa. Randox is currently awaiting product approval from the US FDA and China SFDA.

Dr John Campbell, BSc, PhD said, ‘These new assayed controls will be hugely beneficial to medical laboratories running a wide range of routine patient tests, allowing them to consolidate all or the majority of their QC within one control. ’